Ashley Lora joined an eczema clinical trial for DUPIXENT and paved the way for other Black women to try clinical trials.

Dupixent has received regulatory approvals in more than 60 countries in one or more indications including certain patients with atopic dermatitis ... to treat any other forms of hives (urticaria).

IL-4 and IL-13 inhibitor Dupixent ... form of inflammation – and Sanofi is hoping amlitelimab could be suitable for broader use. The drug has also shown efficacy in a phase 2b atopic dermatitis ...

Despite increasing competition in established indications, Dupixent remains the market leader. In atopic dermatitis ... supply copay assistance in the form of a coupon, et cetera, et cetera.

Dupixent, Adbry, Ebglyss, and Nemluvio are FDA-approved only for the atopic dermatitis form of eczema. It is possible, however, that healthcare providers might also prescribe these medicines off-label ...

Soquelitinib Interim Data from the Atopic Dermatitis Phase 1 Clinical Trial As of May 6, 2025, enrollment into cohorts 1 ... risks detailed in the Quarterly Report on Form 10-Q for the first quarter ...